Prestige Consumer Healthcare Inc. (PBH)
NYSE: PBH · Real-Time Price · USD
58.75
+0.45 (0.77%)
Apr 28, 2026, 4:00 PM EDT - Market closed
PBH Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for PBH stock have an average target of 75.33, with a low estimate of 66 and a high estimate of 88. The average target predicts an increase of 28.22% from the current stock price of 58.75.
Analyst Consensus: Buy
* Price targets were last updated on Feb 2, 2026.
Analyst Ratings
The average analyst rating for PBH stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold Maintains $70 → $66 | Hold | Maintains | $70 → $66 | +12.34% | Feb 2, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $100 → $88 | Strong Buy | Maintains | $100 → $88 | +49.79% | Nov 7, 2025 |
| Jefferies | Jefferies | Hold Maintains $75 → $71 | Hold | Maintains | $75 → $71 | +20.85% | Oct 27, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $82 → $72 | Buy | Maintains | $82 → $72 | +22.55% | Oct 21, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $105 → $100 | Strong Buy | Maintains | $105 → $100 | +70.21% | Aug 8, 2025 |
Financial Forecast
Revenue This Year
1.11B
from 1.14B
Decreased by -2.18%
Revenue Next Year
1.16B
from 1.11B
Increased by 4.31%
EPS This Year
4.59
from 4.29
Increased by 6.89%
EPS Next Year
4.86
from 4.59
Increased by 5.89%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 1.2B | 1.3B | ||||
| Avg | 1.1B | 1.2B | ||||
| Low | 1.1B | 1.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 2.1% | 15.7% | ||||
| Avg | -2.2% | 4.3% | ||||
| Low | -5.3% | -1.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 4.78 | 5.17 | ||||
| Avg | 4.59 | 4.86 | ||||
| Low | 4.44 | 4.64 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | 11.4% | 12.7% | ||||
| Avg | 6.9% | 5.9% | ||||
| Low | 3.5% | 1.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.